Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies (Q33337548)

25 July 2017

title

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies (English)

1 reference

25 July 2017

1 reference

cardiovascular disease

1 reference

Lucy Lennon

11

0 references

Nita G. Forouhi

object named as

Nita G Forouhi

8

0 references

Peter H. Whincup

object named as

Peter H Whincup

17

0 references

Naveed Sattar

1

object named as

Naveed Sattar

1 reference

25 July 2017

16

Rudi G Westendorp

1 reference

25 July 2017

9

Dilys J Freeman

1 reference

25 July 2017

10

J Wouter Jukema

1 reference

25 July 2017

15

David J Stott

1 reference

25 July 2017

19

S Goya Wannamethee

1 reference

25 July 2017

12

Peter W Macfarlane

1 reference

25 July 2017

2

Alex McConnachie

1 reference

25 July 2017

6

Anton J de Craen

1 reference

25 July 2017

7

Ian Ford

1 reference

25 July 2017

A Gerald Shaper

3

1 reference

25 July 2017

Gerard J Blauw

4

1 reference

25 July 2017

Michael B Murphy

13

1 reference

25 July 2017

Chris J Packard

14

1 reference

25 July 2017

James Shepherd

18

1 reference

25 July 2017

Brendan M Buckley

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

22 May 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

371

1 reference

25 July 2017

issue

9628

1 reference

25 July 2017

page(s)

1927-1935

1 reference

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome: a solution in search of a problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

The metabolic syndrome: should current criteria influence clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

The myth of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome increases the risk of ischemic stroke in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Biochemical measures in a population-based study: effect of fasting duration and time of day.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Physical activity and hemostatic and inflammatory variables in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Decreased muscle mass and increased central adiposity are independently related to mortality in older men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Twenty year follow-up of a cohort based in general practices in 24 British towns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

The diabetes risk score: a practical tool to predict type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Blood pressure and mortality in elderly people aged 85 and older: community based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960602-9

7 January 2021

10.1016/S0140-6736(08)60602-9

Identifiers

DOI

1 reference

25 July 2017

1 reference